Last reviewed · How we verify

fix dose r-FSH (Gonal-f)

Sisli Hamidiye Etfal Training and Research Hospital · FDA-approved active Small molecule

fix dose r-FSH (Gonal-f) is a Gonadotropin Small molecule drug developed by Sisli Hamidiye Etfal Training and Research Hospital. It is currently FDA-approved for Ovarian stimulation in women undergoing assisted reproductive technology (ART) including in vitro fertilization (IVF), Anovulation and oligo-ovulation in women seeking pregnancy. Also known as: puregon.

Recombinant follicle-stimulating hormone (r-FSH) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.

Recombinant follicle-stimulating hormone (r-FSH) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment. Used for Ovarian stimulation in women undergoing assisted reproductive technology (ART) including in vitro fertilization (IVF), Anovulation and oligo-ovulation in women seeking pregnancy.

At a glance

Generic namefix dose r-FSH (Gonal-f)
Also known aspuregon
SponsorSisli Hamidiye Etfal Training and Research Hospital
Drug classGonadotropin
TargetFSH receptor (FSHR)
ModalitySmall molecule
Therapeutic areaReproductive Medicine / Fertility
PhaseFDA-approved

Mechanism of action

r-FSH is a recombinant version of the naturally occurring pituitary hormone FSH that binds to FSH receptors on granulosa cells of ovarian follicles, promoting their development and estrogen production. This controlled follicular stimulation is essential for assisted reproductive technologies to obtain multiple mature oocytes for fertilization. The fixed-dose formulation allows standardized dosing during ovarian stimulation cycles.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about fix dose r-FSH (Gonal-f)

What is fix dose r-FSH (Gonal-f)?

fix dose r-FSH (Gonal-f) is a Gonadotropin drug developed by Sisli Hamidiye Etfal Training and Research Hospital, indicated for Ovarian stimulation in women undergoing assisted reproductive technology (ART) including in vitro fertilization (IVF), Anovulation and oligo-ovulation in women seeking pregnancy.

How does fix dose r-FSH (Gonal-f) work?

Recombinant follicle-stimulating hormone (r-FSH) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.

What is fix dose r-FSH (Gonal-f) used for?

fix dose r-FSH (Gonal-f) is indicated for Ovarian stimulation in women undergoing assisted reproductive technology (ART) including in vitro fertilization (IVF), Anovulation and oligo-ovulation in women seeking pregnancy.

Who makes fix dose r-FSH (Gonal-f)?

fix dose r-FSH (Gonal-f) is developed and marketed by Sisli Hamidiye Etfal Training and Research Hospital (see full Sisli Hamidiye Etfal Training and Research Hospital pipeline at /company/sisli-hamidiye-etfal-training-and-research-hospital).

Is fix dose r-FSH (Gonal-f) also known as anything else?

fix dose r-FSH (Gonal-f) is also known as puregon.

What drug class is fix dose r-FSH (Gonal-f) in?

fix dose r-FSH (Gonal-f) belongs to the Gonadotropin class. See all Gonadotropin drugs at /class/gonadotropin.

What development phase is fix dose r-FSH (Gonal-f) in?

fix dose r-FSH (Gonal-f) is FDA-approved (marketed).

What are the side effects of fix dose r-FSH (Gonal-f)?

Common side effects of fix dose r-FSH (Gonal-f) include Ovarian hyperstimulation syndrome (OHSS), Headache, Injection site reactions, Abdominal pain/bloating, Nausea.

What does fix dose r-FSH (Gonal-f) target?

fix dose r-FSH (Gonal-f) targets FSH receptor (FSHR) and is a Gonadotropin.

Related